- The Ebola outbreak in eastern Congo is now the second biggest in history, with 426 confirmed and probable cases, resulting in 245 deaths since Aug. 1.
- Earlier this week, the WHO launched the first-ever clinical trial for potential Ebola treatments in the country.
- It includes Gilead's (NASDAQ:GILD) antiviral Remdesivir and three monoclonal antibody preparations: ZMapp, mAb 114 and Regeneron's (NASDAQ:REGN) 3470-3471-3479.
Congo Ebola outbreak second largest in history
Recommended For You
About GILD Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| GILD | - | - |
| Gilead Sciences, Inc. | ||